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Abstract
Background: ß-Amyloid peptide (Aß), a neutrotoxic sub-
stance, has been implicated to a great degree in cell
death during the course of AD. Resveratrol, a natural
polyphenol mainly found in red wine, has been shown to
be cardioprotective and chemoprotective. Since a mod-
erate wine intake correlates with a lower risk for Alzhei-
mer disease (AD), an additional neuroprotective effect
has been postulated for resveratrol. Objective: The
present study aimed at elucidating the possible neuro-
protective effects of resveratrol against Aß-induced neu-
rotoxicity. Methods: The neuroprotective capacity
against Aß-related oxidative stress was studied in a cell
culture model suitable for studying such potentially neu-
roprotective substances. Results: Resveratrol maintains
cell viability and exerts an anti-oxidative action by en-
hancing the intracellular free-radical scavenger gluta-
thione. Conclusion: Our findings suggest that red wine
may be neuroprotective through the actions of resvera-
trol.
Copyright © 2003 S. Karger AG, Basel
Introduction
Resveratrol (trans-3,4),5-trihydroxylstilbene), a natu-
ral grape-derived polyphenol present in red wine and var-
ious food products, such as peanuts and mulberries, has
been reported to exert neuroprotective, cardioprotective
and cancer chemopreventive activities [1–4]. Red wine
ingredients such as resveratrol are considered to be relat-
ed to the so-called ‘French Paradox’ – a low incidence of
cardiovascular diseases coexisting with high fat diet and
moderate wine consumption [1, 4]. There is evidence that
the cardioprotective properties of resveratrol are based on
counteracting atherosclerosis, platelet aggregation, pro-
atherogenic eicosanoids and lipoprotein alterations [2, 4].
Red wine extracts have been found strongly to inhibit
endothelin-1, a vasoactive peptide involved in the devel-
opment of coronary atherosclerosis [5]. Furthermore, res-
veratrol affects mitogenesis and thereby modulates pro-
cesses related to cancer cell growth [3, 6].
Although the neuroprotective effects of resveratrol are
less well studied, its antioxidant properties attenuating
hippocampal cell death and intracellular reactive oxygen
species [1], neuroprotective activities against excitotoxic
brain damage [7] and anti-apoptotic effects by caspase
activation [8] suggest a broad variety of putative neuro-
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protective actions. A role as a potent antioxidant has pre-
viously been postulated for resveratrol [9, 10], but the
mechanisms of its actions remain to be elucidated [11].
A possible neuroprotective effect is additionally sug-
gested by epidemiological studies observing elderly sub-
jects over 3 years, which showed an inverse relationship
between a moderate (250–500 ml) daily red wine intake
and the incidence of Alzheimer’s disease (AD) [12, 13].
ß-Amyloid peptide (Aß) is the principal constituent of
senile plaques in neurodegenerative disorders such as AD
and contributes to cell death. Here we examined the
antioxidative effects of resveratrol in human-derived SH-
SY5Y neuroblastoma cell cultures [14] against oxidative
stress induced by Aß. The results indicate that resveratrol
maintains call viability and thus possesses distinct neuro-
protective effects.
Methods
Cell Culture Experiments
SH-SY5Y neuroblastoma cells were grown in minimum essential
medium (MEM) containing 10% fetal calf serum (FCS), 100 Ìg/ml
streptomycin sulfate, 100 U/ml penicillin G, and L-glutamine (desig-
nated complete medium) in a humidified air/5% CO2 chamber
37°C, as previously described [15, 16]. Sixteen hours before treat-
ment, FCS-medium was removed and the cells were further incu-
bated in FCS-free MEM containing the neuroblastoma growth sup-
plement N2 (all materials were purchased from Gibco, Life Techno-
logies). An amount of 10 ÌM Aß or 50 ÌM hydrogen peroxide (H2O2)
was used as an inducer of oxidative stress in all experiments. H2O2, a
known stress inducer, was chosen as a positive control to demon-
strate the effect of resveratrol under cytotoxic conditions not caused
by Aß since the induction of oxidative stress in neurodegenerative
disorders appears to be multifactorial. The aggregated Aß(1–42)
form was used for the neurotoxicity experiments (Bachem).
Glutathione Assay
The glutathione (GSH) assay was performed in three indepen-
dent experiments in duplicate in the presence or absence of 15 ÌM
resveratrol. The following concentrations of resveratrol have been
used in preceding gradient experiments to assess the optimum neuro-
protective concentration: 250, 100, 50, 25, 15, 10 and 5 ÌM. In our
experiments, 15 ÌM has been shown to be the minimum concentra-
tion of resveratrol that still shows efficacy. This concentration is less
than most concentrations used in previous studies but approximates
physiological concentrations present in natural products [4, 17].
GSH was measured according to the manufacturer’s instructions
(Clontech, ApoAlert GSH Detection Kit); detailed information has
been presented elsewhere [15]. Each experiment included controls
measuring GSH levels under resveratrol, H2O2 or Aß effects only. In
addition, GSH alterations have been assessed by adding resveratrol
12 h prior to or following the stress conditions induced by Aß or
H2O2. The duration of resveratrol treatment was 24 h for both pre-
and post-incubation experiments.
Cell Viability Assay (MTT Reduction Assay)
Cell viability was determined under toxic conditions (Aß and
H2O2) using an MTT (3-[4,5 dimethylthiazol-2-yl]-2,5-diphenyl-
tetrazolium bromide, Sigma Chemical Co.) assay. Serum-free me-
dium containing either 50 ÌM H2O2 or 10 ÌM Aß in the presence or
absence of 15 ÌM resveratrol was added to the cells for 24 h, 12 h
prior to or following the stress conditions. MTT was added to the
cells, and after incubation in the dark at 37°C for 5 h followed by cell
lysis, the spectrophotometric measurements were performed at
590 nm. Assays were repeated in three independent experiments per-
formed in quadruplicate.
Statistical Analysis
In both GSH and MTT assays, the Kruskal-Wallis test was used
for overall comparison and the Mann-Whitney U test (one-tailed)
was used for single comparison between each stressor (Aß or H2O2)
and resveratrol before and after incubation in the presence of the
same stressor. The level of statistical significance was set at p ! 0.05.
Results
The measurement of intracellular changes in GSH, the
main antioxidant protein within cells from a reduced to
an oxidised form provides a sensitive marker of oxidative
stress [18]. Both 50 ÌM H2O2.and 10 ÌM Aß were found
to induce a distinct decrease in intracellular GSH levels
indicating a distinct neurotoxic activity for both sub-
stances (fig. 1b, c). The GSH suppression was more prom-
inent for H2O2-induced oxidative stress than for Aß
(fig. 1b, c). The administration of 15 ÌM resveratrol was
highly effective in reversing Aß-induced GSH reduction
both in pre- and post-treatment experiments (fig. 1c).
Thus, resveratrol was able to restore completely GSH lev-
els, when compared to the control levels, indicating a res-
veratrol-induced increase of cellular GSH. However,
when the cells were treated prior to or following the induc-
tion of oxidative stress, 15 ÌM resveratrol did not block
the H2O2-induced GSH attenuation (fig. 1b).
To investigate further possible neuroprotective effects
of resveratrol, we performed MTT cytotoxicity assays
assessing the activity of the mitochondrial respiratory
chain [15]. Cell viability as assessed by MTT was distinct-
ly suppressed by H2O2- and Aß-induced oxidative stress
(fig. 2b, c). When cells were pre-incubated with 15 ÌM res-
veratrol they recovered from H2O2 neurotoxicity, whereas
post-incubation with resveratrol was not protective
against H2O2 (fig. 2b). On the other hand, resveratrol both
before and after treatment was able to attenuate Aß-
induced neurotoxicity (fig. 2c). Thus, post-treatment with
resveratrol was more effective in inducting MTT metabo-
lism. Both effects were highly significant.
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Fig. 1. Cellular GSH levels under stress conditions with H2O2 or Aß
and resveratrol (Res) pre- or post-incubation (¯27 = 32.6, p ! 0.001).
a Control experiments showing regular cellular GSH levels (control),
and effects of resveratrol alone. b H2O2 attenuates GSH levels; this
decrease is not reversed by resveratrol pre- or post-incubation. H2O2
vs. resveratrol H2O2 (pre) and vs. H2O2-resveratrol (post): not signifi-
cant. c Resveratrol pre- and post-incubation counteract Aß-induced
GSH reduction. Aß vs. resveratrol-Aß (pre): Z1 = 1.9, p ! 0.05; Aß vs.
Aß-resveratrol (post): Z1 = 1.9. * p ! 0.05.
Fig. 2. Cell viability under H2O2- or Aß-induced neurotoxicity and
resveratrol (Res) pre- or post-incubation (¯27 = 79.1, p ! 0.001).
a MTT control experiments and in the presence of resveratrol.
b H2O2 neurotoxicity is improved by resveratrol pre-incubation but
not by post-incubation. H2O2 vs. Res-H2O2 (pre): Z1 = 4, ** p !
0.001; H2O2 vs. H2O2-resveratrol (post): not significant. c Both res-
veratrol pre- and post-incubation increased cell viability suppressed
by Aß. Aß vs. resveratrol-Aß (pre): Z1 = 3.4, * p ! 0.001; Aß vs. Aß-
resveratrol (post): Z1 = 2.6, ** p ! 0.05.
Discussion
The results of GSH assays underline the antioxidative
properties of resveratrol. Resveratrol was highly effective
in restoring intracellular GSH levels following Aß-in-
duced oxidative stress. Since the GSH levels in the cells
were completely restored under cytotoxic conditions by
resveratrol treatment, a modulatory role in inducing cel-
lular GSH production can be postulated for resveratrol.
On the other hand, resveratrol was not effective in revers-
ing the H2O2-induced oxidative GSH reduction. One
explanation for that may be the physiological, but low,
concentration of resveratrol used in the study.
Although resveratrol was not effective in reversing the
H2O2-induced GSH decrease, it improved cell viability in
MTT assays under the same stress conditions. Indepen-
dently of the recovery effects of resveratrol on GSH levels,
our data suggest that resveratrol may additionally act on
mitochondrial status. The direct effects of resveratrol on
mitochondrial status have been previously reported. This
is substantiated by the chemopreventive activity of res-
veratrol in colon carcinoma cell lines which is primarily
based on apoptosis induced via mitochondria [19]. In
those experiment, the cells were treated with a relatively
high dose, 100 ÌM, of resveratrol [19]. In experiments
using the same cell line as ours, resveratrol showed anti-
apoptotic effects by inhibiting caspase activation when
the cells were treated with higher concentrations (50 ÌM)
of resveratrol [8]. There are some indications for a dose-
dependent effect of resveratrol which is biologically active
even at concentrations as low as 1 ÌM, but the effect is
reversed when higher concentrations (50–100 ÌM) are
used [20]. This may indicate that a moderate intake of
resveratrol may be neuroprotective.
Besides antioxidant and cell viability-enhancing prop-
erties, resveratrol, in naturally available concentrations,
induces phosphorylation of the mitogen-activated protein
(MAP) kinases, ERK1 and ERK2 [20], which play a key
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role in neuronal functions such as synaptic plasticity [21].
Since MPA kinases are activated in the hippocampus dur-
ing associative learning tasks and are necessary for memo-
ry consolidation [22], this effect may additionally support
the neuroactive capabilities of resveratrol in maintaining
cognitive functions.
With the exception of red wine, its most common natu-
ral source [4], resveratrol is not widely found in appro-
priate concentrations in natural products. The highest
concentrations are found in red wines from Cabernet-
Sauvignon, Pinot noir and Merlot grapes [4]. White wines
contain considerably lower resveratrol concentrations.
Therefore, a moderate red wine intake may provide an
adequate natural source of resveratrol [12, 13, 20], keep-
ing in mind that excessive drinking leads to cognitive
deterioration through direct toxic effects of alcohol and
indirectly through nutritional deficiencies [23].
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